EV/EBITDA
-1.55
0.000.00%
4 min ago
Summary
- As of March 10, 2025, OCX EV/EBITDA is -1.55, unchanged from the previous trading day.
- Over the past year, OCX EV/EBITDA has increased by +0.09 (+5.49%).
- OCX EV/EBITDA is now -103.47% below its all-time high of 44.67.
Performance
OCX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
OCX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | -0.1% | -0.1% |
| 1 m1 month | -82.3% | +82.3% | +83.8% |
| 3 m3 months | -52.0% | +51.4% | +52.2% |
| 6 m6 months | -4.7% | +76.2% | +20.2% |
| ytdytd | -59.8% | +59.0% | +59.9% |
| 1 y1 year | +5.5% | +259.9% | +28.1% |
| 5 y5 years | +73.5% | -49.0% | -91.7% |
OCX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -86.8% | -1.55 | at low | |
| 3 m | 3-month | -0.81 | -91.4% | -1.55 | at low |
| 6 m | 6-month | -0.81 | -91.4% | -1.55 | at low |
| 1 y | 1-year | -0.68 | -127.9% | -1.72 | +9.9% |
| 3 y | 3-year | 44.67 | -103.5% | -95.35 | +98.4% |
| 5 y | 5-year | 44.67 | -103.5% | -95.35 | +98.4% |
| alltime | all time | 44.67 | -103.5% | -95.35 | +98.4% |
OncoCyte EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.55(+59.8%) |
| 2024 | -0.97(-23.0%) |
| 2023 | -1.26(-47.5%) |
| 2022 | -2.40(-32.8%) |
| 2021 | -3.57(-37.0%) |
| Date | Value |
|---|---|
| 2020 | -5.67(+9.9%) |
| 2019 | -5.16(+49.6%) |
| 2018 | -3.45(-54.6%) |
| 2017 | -7.60(-57.6%) |
| 2016 | -17.94(+0.4%) |
| 2015 | -17.87 |
FAQ
- What is OncoCyte EV/EBITDA?
- What is the all time high EV/EBITDA for OncoCyte?
- What is OCX EV/EBITDA year-to-date change?
- What is OncoCyte EV/EBITDA year-on-year change?
What is OncoCyte EV/EBITDA?
The current EV/EBITDA of OCX is -1.55
What is the all time high EV/EBITDA for OncoCyte?
OncoCyte all-time high EV/EBITDA is 44.67
What is OCX EV/EBITDA year-to-date change?
OncoCyte EV/EBITDA has changed by -0.58 (-59.79%) since the beginning of the year
What is OncoCyte EV/EBITDA year-on-year change?
Over the past year, OCX EV/EBITDA has changed by +0.09 (+5.49%)